TrialCancer chemotherapy and pharmacology2015

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.

Chu Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.